Literature DB >> 32601694

Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset.

Fernando Morales1, Melissa Vásquez1, Eyleen Corrales1, Rebeca Vindas-Smith1, Carolina Santamaría-Ulloa1, Baili Zhang2, Mario Sirito2, Marcos R Estecio3, Ralf Krahe2, Darren G Monckton4.   

Abstract

In myotonic dystrophy type 1 (DM1), somatic mosaicism of the (CTG)n repeat expansion is age-dependent, tissue-specific and expansion-biased. These features contribute toward variation in disease severity and confound genotype-to-phenotype analyses. To investigate how the (CTG)n repeat expansion changes over time, we collected three longitudinal blood DNA samples separated by 8-15 years and used small pool and single-molecule PCR in 43 DM1 patients. We used the lower boundary of the allele length distribution as the best estimate for the inherited progenitor allele length (ePAL), which is itself the best predictor of disease severity. Although in most patients the lower boundary of the allele length distribution was conserved over time, in many this estimate also increased with age, suggesting samples for research studies and clinical trials should be obtained as early as possible. As expected, the modal allele length increased over time, driven primarily by ePAL, age-at-sampling and the time interval. As expected, small expansions <100 repeats did not expand as rapidly as larger alleles. However, the rate of expansion of very large alleles was not obviously proportionally higher. This may, at least in part, be a result of the allele length-dependent increase in large contractions that we also observed. We also determined that individual-specific variation in the increase of modal allele length over time not accounted for by ePAL, age-at-sampling and time was inversely associated with individual-specific variation in age-at-onset not accounted for by ePAL, further highlighting somatic expansion as a therapeutic target in DM1.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 32601694     DOI: 10.1093/hmg/ddaa123

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.

Authors:  Fernando Morales; Eyleen Corrales; Baili Zhang; Melissa Vásquez; Carolina Santamaría-Ulloa; Hazel Quesada; Mario Sirito; Marcos R Estecio; Darren G Monckton; Ralf Krahe
Journal:  Hum Mol Genet       Date:  2021-12-27       Impact factor: 5.121

2.  An Integrative Analysis of DNA Methylation Pattern in Myotonic Dystrophy Type 1 Samples Reveals a Distinct DNA Methylation Profile between Tissues and a Novel Muscle-Associated Epigenetic Dysregulation.

Authors:  Emma Koehorst; Renato Odria; Júlia Capó; Judit Núñez-Manchón; Andrea Arbex; Miriam Almendrote; Ian Linares-Pardo; Daniel Natera-de Benito; Verónica Saez; Andrés Nascimento; Carlos Ortez; Miguel Ángel Rubio; Jordi Díaz-Manera; Jorge Alonso-Pérez; Giuseppe Lucente; Agustín Rodriguez-Palmero; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Gisela Nogales-Gadea; Mònica Suelves
Journal:  Biomedicines       Date:  2022-06-10

3.  High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1.

Authors:  Astrid Rasmussen; Mathis Hildonen; John Vissing; Morten Duno; Zeynep Tümer; Ulf Birkedal
Journal:  Genes (Basel)       Date:  2022-05-28       Impact factor: 4.141

4.  Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation.

Authors:  Ye Hyun Hwang; Bruce Eliot Hayward; Marwa Zafarullah; Jay Kumar; Blythe Durbin Johnson; Peter Holmans; Karen Usdin; Flora Tassone
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

5.  Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of DMPK in Patients with Myotonic Dystrophy Type 1.

Authors:  Mathis Hildonen; Kirsten Lykke Knak; Morten Dunø; John Vissing; Zeynep Tümer
Journal:  Genes (Basel)       Date:  2020-08-13       Impact factor: 4.096

Review 6.  DNA Mismatch Repair and its Role in Huntington's Disease.

Authors:  Ravi R Iyer; Anna Pluciennik
Journal:  J Huntingtons Dis       Date:  2021

Review 7.  Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1.

Authors:  Stojan Peric; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic Stojanovic; Giovanni Meola
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

8.  Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1.

Authors:  Emma Koehorst; Judit Núñez-Manchón; Alfonsina Ballester-López; Miriam Almendrote; Giuseppe Lucente; Andrea Arbex; Jakub Chojnacki; Rafael P Vázquez-Manrique; Ana Pilar Gómez-Escribano; Guillem Pintos-Morell; Jaume Coll-Cantí; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Mònica Suelves; Gisela Nogales-Gadea
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

9.  Detection of low-level parental somatic mosaicism for clinically relevant SNVs and indels identified in a large exome sequencing dataset.

Authors:  Daniel D Domogala; Tomasz Gambin; Roni Zemet; Chung Wah Wu; Katharina V Schulze; Yaping Yang; Theresa A Wilson; Ido Machol; Pengfei Liu; Paweł Stankiewicz
Journal:  Hum Genomics       Date:  2021-12-20       Impact factor: 6.481

10.  Robust Detection of Somatic Mosaicism and Repeat Interruptions by Long-Read Targeted Sequencing in Myotonic Dystrophy Type 1.

Authors:  Antoine Mangin; Laure de Pontual; Yu-Chih Tsai; Laetitia Monteil; Mathilde Nizon; Pierre Boisseau; Sandra Mercier; Janet Ziegle; John Harting; Cheryl Heiner; Geneviève Gourdon; Stéphanie Tomé
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.